Evidence map›Paper›PMID 42380167›Full record

ArticleScientific reports2026

Topological modeling of gene expression in the brain with Huntington's disease reveals selective disruption of co-expression network.

Yuko Okamura-Oho, Kazuro Shimokawa, Satoshi Oota, Atsushi Yoshiki, Masahiko Morita, Masaomi Nishimura, Sakiko Nakamura, Yuki Tsujimura, Shumpei Ishikawa, Hideo Yokota

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yuko Okamura-OhoRIKEN Center for Advanced Photonics, Wako, 351-0198, Saitama, Japan. yoho-tky@umin.ac.jp.
Kazuro ShimokawaDepartment of Preventive Medicine, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.
Satoshi OotaRIKEN Center for Advanced Photonics, Wako, 351-0198, Saitama, Japan.
Atsushi YoshikiRIKEN Bioresource Research Center, Tsukuba, Ibaraki, Japan.
Masahiko MoritaRIKEN Center for Advanced Photonics, Wako, 351-0198, Saitama, Japan.
Masaomi NishimuraRIKEN Center for Advanced Photonics, Wako, 351-0198, Saitama, Japan.
Sakiko NakamuraRIKEN Center for Advanced Photonics, Wako, 351-0198, Saitama, Japan.
Yuki TsujimuraRIKEN Center for Advanced Photonics, Wako, 351-0198, Saitama, Japan.
Shumpei IshikawaDepartment of Preventive Medicine, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.
Hideo YokotaRIKEN Center for Advanced Photonics, Wako, 351-0198, Saitama, Japan.

Funding

Japan Society for the Promotion of Science 25560428, 26280110, 268032, 15HP8038, 16HP8032, and 17HP8082Japan Society for the Promotion of Science JP15H05954
6 · The paper itself

Abstract

We applied transcriptome tomography to create a whole-brain model of early-stage Huntington's disease (HD) in R6/2 mice, which ubiquitously express truncated human mutant HTT containing approximately 150 CAG repeats. Medium spiny neuron (MSN)-related genes showed abnormal expression in the HD brain, in terms of expression similarity to wild-type Htt. Bdnf was the most probable upstream regulator of these genes. Smarca4, the Bdnf-regulator, was similarly expressed to wild-type Htt in the control brain; however, this was not observed in HD, implying a possible involvement of Smarca4 in glutamate excitotoxicity in HD. Lhx6, a master gene for MSN-related pathway development ordinarily conserved postnatally and in adulthood, was lost in the HD co-expression network. And a network hub node, Fcho1, was lost in connection involving Lhx6 and mitochondrial gene clusters. Loss of Smarca4, Lhx6, and Fcho1 in co-expression may contribute to spatiotemporally specific neuronal loss in HD.

Indexed as

BrainGene Expression RegulationGene Regulatory NetworksHuntington DiseaseAnimalsBrain-Derived Neurotrophic FactorDisease Models, AnimalDNA HelicasesGene Expression ProfilingHumansHuntingtin ProteinLIM-Homeodomain ProteinsMedium Spiny NeuronsMiceMice, TransgenicNerve Tissue ProteinsBrain-Derived Neurotrophic FactorDNA HelicasesHuntingtin ProteinLIM-Homeodomain ProteinsNerve Tissue ProteinsNuclear ProteinsTranscription Factors

Identifiers

PMID42380167
PMCPMC13319467

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.